Sofosbuvir/Ledipasvir (SOF/LDV) has been approved by the European Medicine Agency (EMA) for the treatment of children and adolescents (at least 3 years of age) with chronic hepatitis C (CHC) genotype 1, 3, and 4 infection. The aim of this study was to evaluate the efficacy and safety of SOF/LDV in adolescents (12 to <18 years old) with CHC in the real-world setting.

Efficacy of Sofosbuvir/Ledipasvir in Adolescents With Chronic Hepatitis C Genotypes 1, 3, and 4: A Real-world Study / Serranti, Daniele; Nebbia, Gabriella; Cananzi, Mara; Nicastro, Emanuele; DI DATO, Fabiola; Nuti, Federica; Garazzino, Silvia; Silvestro, Erika; Giacomet, Vania; Forlanini, Federica; Pinon, Michele; Luigi Calvo, Pier; Riva, Silvia; Dodi, Icilio; Marta Cangelosi, Antonina; Antonucci, Roberto; Ricci, Silvia; Bartolini, Elisa; Mastrangelo, Greta; Trapani, Sandra; Lenge, Matteo; Gaio, Paola; Vajro, Pietro; Iorio, Raffaele; D'Antiga, Lorenzo; Indolfi, Giuseppe. - In: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. - ISSN 1536-4801. - 72:1(2021), pp. 95-100. [10.1097/MPG.0000000000002900]

Efficacy of Sofosbuvir/Ledipasvir in Adolescents With Chronic Hepatitis C Genotypes 1, 3, and 4: A Real-world Study

Emanuele Nicastro;Fabiola Di Dato;Pietro Vajro;Raffaele Iorio;
2021

Abstract

Sofosbuvir/Ledipasvir (SOF/LDV) has been approved by the European Medicine Agency (EMA) for the treatment of children and adolescents (at least 3 years of age) with chronic hepatitis C (CHC) genotype 1, 3, and 4 infection. The aim of this study was to evaluate the efficacy and safety of SOF/LDV in adolescents (12 to <18 years old) with CHC in the real-world setting.
2021
Efficacy of Sofosbuvir/Ledipasvir in Adolescents With Chronic Hepatitis C Genotypes 1, 3, and 4: A Real-world Study / Serranti, Daniele; Nebbia, Gabriella; Cananzi, Mara; Nicastro, Emanuele; DI DATO, Fabiola; Nuti, Federica; Garazzino, Silvia; Silvestro, Erika; Giacomet, Vania; Forlanini, Federica; Pinon, Michele; Luigi Calvo, Pier; Riva, Silvia; Dodi, Icilio; Marta Cangelosi, Antonina; Antonucci, Roberto; Ricci, Silvia; Bartolini, Elisa; Mastrangelo, Greta; Trapani, Sandra; Lenge, Matteo; Gaio, Paola; Vajro, Pietro; Iorio, Raffaele; D'Antiga, Lorenzo; Indolfi, Giuseppe. - In: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. - ISSN 1536-4801. - 72:1(2021), pp. 95-100. [10.1097/MPG.0000000000002900]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/889775
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 11
social impact